← Open Payments lookup

RAVIKUMAR BHALAVAT: Open Payments

NPI 1447406624 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$369 in 29 payments from 7 companies in 2025. Trend: 2023 $152 · 2024 $264 · 2025 $369

Food & beverage: $369
CompanyPaymentsAmount
ABBVIE INC.21$225
E.R. Squibb & Sons, L.L.C.2$43
Otsuka America Pharmaceutical, Inc.2$37
Neurocrine BioSciences, Inc.1$19
Teva Pharmaceuticals USA, Inc.1$16
Lundbeck LLC1$14
Currax Pharmaceuticals LLC1$14

Products named: VRAYLAR, REXULTI, COBENFY, INGREZZA, UZEDY, ONZETRA XSAIL.

Industry payments across MD — which companies pay providers there.